These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 33663953)
1. Context-Dependent Glioblastoma-Macrophage/Microglia Symbiosis and Associated Mechanisms. Xuan W; Lesniak MS; James CD; Heimberger AB; Chen P Trends Immunol; 2021 Apr; 42(4):280-292. PubMed ID: 33663953 [TBL] [Abstract][Full Text] [Related]
2. Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma. Pang L; Khan F; Heimberger AB; Chen P Trends Cancer; 2022 Oct; 8(10):839-854. PubMed ID: 35624002 [TBL] [Abstract][Full Text] [Related]
3. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma. Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T Front Immunol; 2021; 12():637053. PubMed ID: 34108959 [TBL] [Abstract][Full Text] [Related]
4. Exploiting Microglial Functions for the Treatment of Glioblastoma. Dello Russo C; Lisi L; Tentori L; Navarra P; Graziani G; Combs CK Curr Cancer Drug Targets; 2017; 17(3):267-281. PubMed ID: 27528361 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological targeting of the tumor-immune symbiosis in glioblastoma. Pang L; Khan F; Dunterman M; Chen P Trends Pharmacol Sci; 2022 Aug; 43(8):686-700. PubMed ID: 35534356 [TBL] [Abstract][Full Text] [Related]
6. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts. Yabo YA; Moreno-Sanchez PM; Pires-Afonso Y; Kaoma T; Nosirov B; Scafidi A; Ermini L; Lipsa A; Oudin A; Kyriakis D; Grzyb K; Poovathingal SK; Poli A; Muller A; Toth R; Klink B; Berchem G; Berthold C; Hertel F; Mittelbronn M; Heiland DH; Skupin A; Nazarov PV; Niclou SP; Michelucci A; Golebiewska A Genome Med; 2024 Apr; 16(1):51. PubMed ID: 38566128 [TBL] [Abstract][Full Text] [Related]
7. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival. Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630 [TBL] [Abstract][Full Text] [Related]
8. Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy. Lin C; Wang N; Xu C Front Immunol; 2023; 14():1123853. PubMed ID: 36969167 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment. Hong S; You JY; Paek K; Park J; Kang SJ; Han EH; Choi N; Chung S; Rhee WJ; Kim JA Theranostics; 2021; 11(19):9687-9704. PubMed ID: 34646393 [No Abstract] [Full Text] [Related]
10. Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities. Wang G; Zhong K; Wang Z; Zhang Z; Tang X; Tong A; Zhou L Front Immunol; 2022; 13():964898. PubMed ID: 35967394 [TBL] [Abstract][Full Text] [Related]
11. Single-Cell Transcriptome Profiling Signatures and Alterations of Microglia Associated With Glioblastoma Associate Microglia Contribution to Tumor Formation. Xia H; Deng L; Meng S; Liu X; Zheng C Pathol Oncol Res; 2022; 28():1610067. PubMed ID: 35693633 [TBL] [Abstract][Full Text] [Related]
12. Macrophages and microglia: the cerberus of glioblastoma. Buonfiglioli A; Hambardzumyan D Acta Neuropathol Commun; 2021 Mar; 9(1):54. PubMed ID: 33766119 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of Cathepsin X in Glioblastoma: Interplay with γ-Enolase and the Effects of Selective Cathepsin X Inhibitors. Majc B; Habič A; Novak M; Rotter A; Porčnik A; Mlakar J; Župunski V; Pečar Fonović U; Knez D; Zidar N; Gobec S; Kos J; Lah Turnšek T; Pišlar A; Breznik B Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163706 [TBL] [Abstract][Full Text] [Related]
14. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma. DeCordova S; Shastri A; Tsolaki AG; Yasmin H; Klein L; Singh SK; Kishore U Front Immunol; 2020; 11():1402. PubMed ID: 32765498 [TBL] [Abstract][Full Text] [Related]
15. Insights in the immunobiology of glioblastoma. Strepkos D; Markouli M; Klonou A; Piperi C; Papavassiliou AG J Mol Med (Berl); 2020 Jan; 98(1):1-10. PubMed ID: 31650201 [TBL] [Abstract][Full Text] [Related]
16. Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition. Rao R; Han R; Ogurek S; Xue C; Wu LM; Zhang L; Zhang L; Hu J; Phoenix TN; Waggoner SN; Lu QR Neuro Oncol; 2022 Apr; 24(4):584-597. PubMed ID: 34562087 [TBL] [Abstract][Full Text] [Related]
17. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy. Khan F; Pang L; Dunterman M; Lesniak MS; Heimberger AB; Chen P J Clin Invest; 2023 Jan; 133(1):. PubMed ID: 36594466 [TBL] [Abstract][Full Text] [Related]
18. Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastoma. Finotto L; Cole B; Giese W; Baumann E; Claeys A; Vanmechelen M; Decraene B; Derweduwe M; Dubroja Lakic N; Shankar G; Nagathihalli Kantharaju M; Albrecht JP; Geudens I; Stanchi F; Ligon KL; Boeckx B; Lambrechts D; Harrington K; Van Den Bosch L; De Vleeschouwer S; De Smet F; Gerhardt H EMBO Mol Med; 2023 Nov; 15(11):e18144. PubMed ID: 37791581 [TBL] [Abstract][Full Text] [Related]
19. Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma. Pires-Afonso Y; Niclou SP; Michelucci A Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973030 [No Abstract] [Full Text] [Related]